Research priorities towards precision antibiotic therapy to improve patient care

ZP Bulman, SG Wicha, EI Nielsen, JR Lenhard… - The Lancet …, 2022 - thelancet.com
Antibiotic resistance presents an incessant threat to our drug armamentarium that
necessitates novel approaches to therapy. Over the past several decades, investigation of …

Novel insights into the complex pharmacokinetics of voriconazole: a review of its metabolism

J Schulz, F Kluwe, G Mikus, R Michelet… - Drug metabolism …, 2019 - Taylor & Francis
Voriconazole, a second-generation triazole frequently used for the prophylaxis and
treatment of invasive fungal infections, undergoes complex metabolism mainly involving …

[HTML][HTML] Towards precision dosing of vancomycin: a systematic evaluation of pharmacometric models for Bayesian forecasting

A Broeker, M Nardecchia, KP Klinker… - Clinical Microbiology …, 2019 - Elsevier
Objectives Vancomycin is a vital treatment option for patients suffering from critical
infections, and therapeutic drug monitoring is recommended. Bayesian forecasting is …

[HTML][HTML] Exploring protein binding of uremic toxins in patients with different stages of chronic kidney disease and during hemodialysis

O Deltombe, W Van Biesen, G Glorieux, Z Massy… - Toxins, 2015 - mdpi.com
As protein binding of uremic toxins is not well understood, neither in chronic kidney disease
(CKD) progression, nor during a hemodialysis (HD) session, we studied protein binding in …

Protein binding characteristics and pharmacokinetics of ceftriaxone in intensive care unit patients

M Schleibinger, CL Steinbach, C Töpper… - British journal of …, 2015 - Wiley Online Library
Aims The aim of the present study was to assess the pharmacokinetics of total and unbound
ceftriaxone in intensive care unit (ICU) patients and its protein binding characteristics …

Hypoalbuminemia and pharmacokinetics: when the misunderstanding of a fundamental concept leads to repeated errors over decades

P Gandia, S Decheiver, M Picard, R Guilhaumou… - Antibiotics, 2023 - mdpi.com
Surprisingly, misinterpretation of the influence of hypoalbuminemia on pharmacokinetics
and the clinical effects of drugs seems to be a current problem, even though …

Pharmacokinetic/pharmacodynamic considerations for the optimization of antimicrobial delivery in the critically ill

D Tsai, J Lipman, JA Roberts - Current opinion in critical care, 2015 - journals.lww.com
Optimization of antimicrobial dosing in accordance with pharmacokinetics/
pharmacodynamics targets can improve survival and clinical cure. Dosing regimens for …

Assays for therapeutic drug monitoring of β-lactam antibiotics: a structured review

M Carlier, V Stove, SC Wallis, JJ De Waele… - International journal of …, 2015 - Elsevier
In some patient groups, including critically ill patients, the pharmacokinetics of β-lactam
antibiotics may be profoundly disturbed due to pathophysiological changes in distribution …

Pharmacokinetics and pharmacodynamics of peptide antibiotics

X Bian, X Qu, J Zhang, SC Nang, PJ Bergen… - Advanced drug delivery …, 2022 - Elsevier
Antimicrobial resistance is a major global health challenge. As few new efficacious
antibiotics will become available in the near future, peptide antibiotics continue to be major …

[HTML][HTML] How to design a study to evaluate therapeutic drug monitoring in infectious diseases?

AG Märtson, MGG Sturkenboom, J Stojanova… - Clinical Microbiology …, 2020 - Elsevier
Background Therapeutic drug monitoring (TDM) is a tool to personalize and optimize dosing
by measuring the drug concentration and subsequently adjusting the dose to reach a target …